FDA Inspection 1121935 — Kyowa Kirin Pharmaceutical Research, Inc.
The FDA completed an inspection of Kyowa Kirin Pharmaceutical Research, Inc. on March 6, 2020 in La Jolla, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- March 6, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- La Jolla, CA (United States)
Additional Details
Bioanalytical BA/BE